Medical Digest & Congress Report

The New 2025 Guideline for Acute Coronary Syndromes: The European perspective - report from AHA 2025

01 Dec 2025

Contributed by Lukas

Professor Tiziana Claudia Aranzulla shares her insights on the Guideline for Acute Coronary Syndromes from the European perspective at AHA Scientific ...

State of the art tumor-targeting IL-12 immunocytokine therapies - report from SITC 2025

27 Nov 2025

Contributed by Lukas

Dr. Gregory Conn shares his insights on state of the art tumor-targeting IL-12 immunocytokine therapies after SITC's 40th Anniversary Annual Meeti...

Reprogramming the Immune Microenvironment to Intercept Lung Adenocarcinoma Precancer - report from SITC 2025

27 Nov 2025

Contributed by Lukas

Professor Jianjun Zhang shares his insights on reprogramming the immune microenvironment to intercept lung adenocarcinoma precancer at SITC's 40th...

Primary analysis of patients with high-risk localized, locally recurrent, or regionally advanced cutaneous squamous cell carcinoma treated with neoadjuvant PD-1 therapy - report from SITC 2025

27 Nov 2025

Contributed by Lukas

Professor Gino In presented data from the NeoPOWER trial, to study the role of neoadjuvant PD-1 alone in CSCC at SITC's 40th Anniversary Annual Me...

Phase I Trial of DOC1021 Cell-Based Immunotherapy for Resectable or Borderline Resectable Pancreatic Ductal Adenocarcinoma - report from SITC 2025

27 Nov 2025

Contributed by Lukas

Professor William Decker discusses the Phase I Trial of DOC1021 cell-based immunotherapy for resectable or borderline resectable pancreatic ductal ade...

How to optimize PD1/PDL1 treatment? - report from SITC 2025

27 Nov 2025

Contributed by Lukas

Professor Gordon J. Freeman shares his insights on how to optimize PD1/PDL1 treatment at SITC's 40th Anniversary Annual Meeting.Video: https://med...

Modulating the Tumor Microenvironment with T Cell Bispecifics - report from SITC 2025

27 Nov 2025

Contributed by Lukas

Professor Sumit K. Subudhi shares his insights on modulating the tumor microenvironment with T Cell bispecifics at SITC's 40th Anniversary Annual ...

Comparative Cardioprotective Effects of GLP-1 Receptor Agonists versus SGLT2 Inhibitors in Pulmonary Arterial Hypertension: Insights from a Large-Scale Real-World data analysis

27 Nov 2025

Contributed by Lukas

Dr. Saud Alawad and Prof. Sunil Sharma discuss the comparative cardioprotective effects of GLP-1 receptor agonists versus SGLT2 inhibitors in pulmonar...

Ensifentrine treatment improves COPD symptoms and quality of life in a pooled analysis of the ENHANCE trials - report from CHEST 2025

27 Nov 2025

Contributed by Lukas

Professor Nicola Hanania discuss the lessons from the ENHANCE trials were presented at the American College of Chest Physicians (CHEST) 2025 Annual Me...

Sleep Apnea Significantly Impacts Mortality Benefit of GLP-1s - report from CHEST 2025

27 Nov 2025

Contributed by Lukas

Dr. Cosmo Fowler explains thet data revealed one-year mortality in patients with type 2 diabetes prescribed GLP-1 RAs was substantially lower than tho...

Advances in the Development of Therapeutic Targets in the Platelet for Prevention of Thrombosis - report from AHA 2025

26 Nov 2025

Contributed by Lukas

Professor Paola Patrignani shares her insights on the advances in the development of therapeutic targets in the platelet for prevention of thrombosis ...

Long-term Efficacy and Safety of Lerodalcibep in the Open-label 72-week Extension Study of Subjects Previously on Inclisiran or Lerodalcibep in the LIBerate-VI Trial - report from AHA 2025

26 Nov 2025

Contributed by Lukas

Dr. Evan A Stein shares his insights on the emerging opportunities for managing cardiometabolic syndrome at AHA Scientific Sessions 2025.Video: https:...

2025 AHA Blood Pressure Guideline & CKD Management: Key Insights and Global Perspectives - report from AHA 2025

26 Nov 2025

Contributed by Lukas

Professor Eugene Yang shares his insights on the 2025 AHA Blood Pressure Guideline & CKD Management at AHA Scientific Sessions 2025.Video: https:/...

Lipid Lowering Therapies and Lipid Risk Factors - report from AHA 2025

26 Nov 2025

Contributed by Lukas

Professor Samia Mora explains her opinion on lipid lowering therapies and lipid risk factors at AHA Scientific Sessions 2025.Video: https://medicaldig...

The New 2025 Guideline for Acute Coronary Syndromes - report from AHA 2025

26 Nov 2025

Contributed by Lukas

Professor Debabrata Mukherjee shares his insights on the Guideline for Acute Coronary Syndromes at AHA Scientific Sessions 2025.Video: https://medical...

Aortic Regurgitation: The New Frontier - Imaging, Interventions, and the Future of Treatment - report from AHA 2025

26 Nov 2025

Contributed by Lukas

Professor Robert O. Bonow shares his insights on aortic regurgitation, imaging, interventions, and the future of treatment at AHA Scientific Sessions ...

Immuno-oncology biomarkers in locally advanced HNSCC - lessons from the KeyNote-689 trial - report from ESMO 2025

14 Nov 2025

Contributed by Lukas

Professor Cécile Badoual shares her thoughts on the immuno-oncology biomarkers in locally advanced HNSCC and explains the lessons from the KeyNote-68...

Novelties of the treatment of colon cancer at ESMO 2025

14 Nov 2025

Contributed by Lukas

Professor Julien Taieb shares his thoughts on the novelties of the treatment of colon cancer at the ESMO Congress 2025.Video: https://medicaldigest.or...

How to PROC - Breaking the Wall of Platinum-Resistance in Ovarian Cancer - report from ESMO 2025

14 Nov 2025

Contributed by Lukas

Professor Jalid Sehouli explains how to break the wall of platinum-resistance in ovarian cancer at the ESMO Congress 2025.Video: https://medicaldigest...

IMvigor011: A Phase 3 Trial of ctDNA-Guided Adjuvant Atezolizumab versus Placebo in MIBC - report from ESMO 2025

14 Nov 2025

Contributed by Lukas

Professor Thomas B. Powles discuss the results from IMvigor011, a phase 3 trial of ctDNA-guided adjuvant atezolizumab versus placebo in muscle invasiv...

T-DXd Effective for Treating HER2+ Advanced or Metastatic Breast Cancer, Regardless of Treatment History, HR Status, or PIK3C Mutations - report from ESMO 2025

14 Nov 2025

Contributed by Lukas

Professor Sibylle Loibl shares her thoughts on the additional analyses of DESTINY-Breast09 were presented at the ESMO Congress 2025. Key subgroup anal...

What's new in ESMO guidelines? - report from ESMO 2025

14 Nov 2025

Contributed by Lukas

Professor Emanuela Romano explains what's new in ESMO guidelines on hepatocellular carcinoma, cutaneous melanoma, Hodgkin Lymphomas and early stag...

DYNAMIC-III trial results: ctDNA blood test is a powerful tool to guide treatment choices for people with advanced colon cancer - report from ESMO 2025

13 Nov 2025

Contributed by Lukas

Professor Jeanne Tie shares her thoughts on the DYNAMIC-III trial results were presented at the ESMO Congress 2025.Video: https://medicaldigest.org/sc...

Overcoming Therapeutic Challenges in High-risk Cutaneous Squamous Cell Carcinoma: A Multidisciplinary Approach - report from ESMO 2025

13 Nov 2025

Contributed by Lukas

Professor Dirk Schadendorf shares his thoughts on the overcoming therapeutic challenges in high-risk cutaneous squamous cell carcinoma at the ESMO Con...

KEYNOTE-905 Paves the Way for Next Generation of MIBC Trials - report from ESMO 2025

13 Nov 2025

Contributed by Lukas

Professor Christof Vulsteke shares her thoughts on the data from the phase 3 KEYNOTE-905 trial were presented at the ESMO Congress 2025. A treatment r...

Durvalumab in Combination with BCG for BCG-Naïve High-Risk NMIBC: Final Analysis of the Phase 3, Open-Label, Randomized POTOMAC Trial - report from ESMO 2025

13 Nov 2025

Contributed by Lukas

Professor Maria De Santis shares her thoughts on the final analysis of the phase 3, open-Label, randomized POTOMAC trial were presented at the ESMO Co...

Treatment Landscape in Resectable LA HNSCC - report from ESMO 2025

13 Nov 2025

Contributed by Lukas

Professor Hisham M. Mehanna shares his thoughts on the treatment landscape in resectable LA HNSCC at ESMO 2005 at the ESMO Congress 2025.Video: https:...

Analysis of Second Primary Cutaneous Squamous Cell Carcinoma Tumors Reported During the C-POST Trial - report from ESMO 2025

13 Nov 2025

Contributed by Lukas

Professor Danny Rischin shares his thoughts on the analysis of second primary cutaneous squamous cell carcinoma tumors reported during the C-POST tria...

Unlocking the potential of radioligand therapy for advanced prostate cancer - report from ESMO 2025

13 Nov 2025

Contributed by Lukas

Professor Irene Burger explains how to unlock the potential of radioligand therapy for advanced prostate cancer at the ESMO Congress 2025.Video: https...

Thoracic oncology - Lung cancer screening updates: switch gears to move forward - report from ERS 2025

13 Oct 2025

Contributed by Lukas

Prof. Andriani Charpidou co-chaired a very interesting session at this year's ERS congress on lung cancer screening updates.Video: https://medical...

Advancing lung cancer care with real-world evidence, artificial intelligence and computerised clinical guidelines - report from ERS 2025

13 Oct 2025

Contributed by Lukas

Prof. Job F.M. van Boven co-chaired a very interesting session at this year's ERS congress on advancing lung cancer care with real-world evidence,...

Horizon scanning in the treatment of interstitial lung diseases- report from ERS 2025

13 Oct 2025

Contributed by Lukas

Dr. Nazia Chaudhuri co-chaired a very interesting session at this year's ERS congress on horizon scanning in the treatment of interstitial lung di...

Addressing the generational challenge in lung health amidst the growing number of novel tobacco products - report from ERS 2025

13 Oct 2025

Contributed by Lukas

Prof. Andrew Bush share his thoughts on the generational challenge in lung health amidst the growing number of novel tobacco products at ERS Congress ...

The emerging therapeutic interventions for the management of interstitial lung diseases - report from ERS 2025

13 Oct 2025

Contributed by Lukas

Prof. Michael Kreuter co-chaired a very interesting session at this year's ERS congress on the emerging therapeutic interventions for the manageme...

Current controversies in interstitial lung diseases - report from ERS 2025

13 Oct 2025

Contributed by Lukas

Prof. Catharina Moor co-chaired a very interesting session at this year's ERS congress on the current controversies in interstitial lung diseases....

Prevention in action: prevention in the joint action on respiratory disease - report from ERS 2025

13 Oct 2025

Contributed by Lukas

Prof. Ildiko Horvath share her thoughts on prevention in the joint action on respiratory disease at ERS Congress 2025.Video: https://medicaldigest.org...

Understanding aging mechanisms and their effect in asthma - report from ERS 2025

09 Oct 2025

Contributed by Lukas

Dr. Stefania Principe share her thoughts on the understanding aging mechanisms and their effect in asthma at ERS Congress 2025Video: https://medicaldi...

Lung cancer and severe respiratory comorbidities: navigating complex clinical challenges - report from ERS 2025

09 Oct 2025

Contributed by Lukas

Prof. Mohammed Munavvar co-chaired a very interesting session at this year's ERS congress on lung cancer and severe respiratory comorbidities, how...

Benefits of twice daily inhaler dosage in the treatment of COPD - report from ERS 2025

09 Oct 2025

Contributed by Lukas

Prof. Claus Vogelmeier share his thoughts on the benefits of twice daily inhaler dosage in the treatment of COPD at ERS Congress 2025.Video: https://m...

Real-life effectiveness of aclidinium/formoterol in COPD control: preliminary results of the REDACT observational study - report from ERS 2025

09 Oct 2025

Contributed by Lukas

Prof. Konstantinos Kostikas share his thoughts on the real-life effectiveness of aclidinium/formoterol in COPD control at ERS Congress 2025.Video: htt...

Severe asthma: from the underlying mechanism to clinical remission - report from ERS 2025

09 Oct 2025

Contributed by Lukas

Prof. Fabio Ricciardolo co-chaired a very interesting session at this year's ERS congress on severe asthma, from the underlying mechanism to clini...

Unlocking new pathways: emerging therapeutic targets in asthma and COPD - report from ERS 2025

09 Oct 2025

Contributed by Lukas

Prof. Ian M. Adcock co-chaired a very interesting session at this year's ERS congress on the emerging therapeutic targets in asthma and COPD.Video...

Epidemiology of asthma, including severe asthma - report from ERS 2025

09 Oct 2025

Contributed by Lukas

Prof. Joan B. Soriano co-chaired a very interesting session at this year's ERS congress on the epidemiology of asthma, including severe asthma.Vid...

Unmasking COPD: Recognizing Early Signs and Tailoring Treatment - report from ERS 2025

09 Oct 2025

Contributed by Lukas

Professor Federico Lavorini share his thoughts on the power of personalized inhalers at this year's ERS congress.Video: https://medicaldigest.org/...

Novelties in hypertension at ESC 2025

11 Sep 2025

Contributed by Lukas

Professor Anna Dominiczak co-chaired the Late-Breaking Clinical Trials Session on Hypertension at the ESC 2025 annual congress where the presentations...

Evolution of anticoagulation therapy in patients with atrial fibrillation - report from ESC 2025

11 Sep 2025

Contributed by Lukas

Professor Robert Giugliano shared his insights on the evolution of anticoagulation therapy in patients with atrial fibrillation after ESC 2025 Congres...

Cardiac myosin inhibitors in the daily practice - report from ESC 2025

10 Sep 2025

Contributed by Lukas

Professor Milind Desai shared his insights on cardiac myosin inhibitors for management of obstructive hypertrophic cardiomyopathy beyond the clinical ...

Kidney function and coronary artery disease - lessons from the EUROASPIRE IV and V studies

10 Sep 2025

Contributed by Lukas

Professor Lars Ryden shared his insights from the EUROASPIRE IV and V studies on kidney function and coronary artery disease after ESC 2025 Congress.V...

2025 ESC Guidelines for the Management of Cardiovascular Disease and Pregnancy

09 Sep 2025

Contributed by Lukas

Professor Julie De Backer co-chaired the 2025 ESC Guidelines for the management of cardiovascular disease and pregnancy at ESC 2025 Congress.Video: ht...

New insights in the management of hypertrophic cardiomyopathy: exploring the clinical spectrum - report from ESC 2025

09 Sep 2025

Contributed by Lukas

Professor Iacopo Olivotto shared the new insights in the management of hypertrophic cardiomyopathy at ESC 2025 Congress.Video: https://medicaldigest.o...

2025 ESC Consensus Statement on Mental Health and Cardiovascular Disease

09 Sep 2025

Contributed by Lukas

Professor Christi Deaton co-chaired the 2025 ESC consensus statement on mental health and cardiovascular disease at ESC 2025 Congress.Video: https://m...

The importance of influenza vaccination in older people - report from ESC 2025

08 Sep 2025

Contributed by Lukas

Professor Massimo Volpe chaired an interesting session on the importance of influenza vaccination in older people at ESC 2025 Congress.Video: https://...

2025 ESC Guidelines for the Management of Myocarditis and Pericarditis

08 Sep 2025

Contributed by Lukas

Professor Jeanette Schulz-Menger co-chaired the 2025 ESC Guidelines for the management of myocarditis and pericarditis at ESC 2025 Congress.Video: htt...

2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease

08 Sep 2025

Contributed by Lukas

Professor Fabien Praz co-chaired the 2025 ESC/EACTS guidelines for the management of valvular heart disease at ESC 2025 Congress.Vidoe: https://medica...

2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias

08 Sep 2025

Contributed by Lukas

Professor Francois Mach co-chaired the 2025 focused update of the 2019 ESC/EAS guidelines for the management of dyslipidaemias at ESC 2025 Congress.Vi...

The importance of early detection and diagnosis of dementia

28 Aug 2025

Contributed by Lukas

We asked Professor Rebecca Edelmayer, Vice President of Scientific Engagement at the Alzheimer's Association about important news about the diag...

Antirheumatic drugs in reproduction, pregnancy, and lactation: a systematic literature review informing the 2024 update of the EULAR recommendations

01 Aug 2025

Contributed by Lukas

Professor Frauke Förger shares his insights on antirheumatic drugs in reproduction, pregnancy, and lactation. Gave a systematic literature review inf...

What is New in systemic lupus erythematosus?

14 Jul 2025

Contributed by Lukas

Professor Antonis Fanouriakis shares his insights on what is new in systemic lupus erythematosus at EULAR 2024.Video: https://medicaldigest.org/scient...

How to treat elevated TG in other high risk patients - report from WCCL 2025

07 Jul 2025

Contributed by Lukas

Professor Thomas Stulnig shares his insights on how to treat elevated TG in other high risk patients at the 4th World Congress of Lipidology in Vienna...

The lower the better: never mind future drugs, use what you have available to fullest extent and lower cardiovascular risk aggressively - report from WCCL 2025

07 Jul 2025

Contributed by Lukas

Professor Peter Toth shares his insights on how to lower cardiovascular risk at the 4th World Congress of Lipidology in Vienna, Austria.Video: https:/...

How to treat elevated Lp(a) - report from WCCL 2025

07 Jul 2025

Contributed by Lukas

Professor Karam Kostner shares his insights how to treat elevated Lp(a) at the 4th World Congress of Lipidology in Vienna, Austria?Video: https://medi...

What clinicians must know about diabetic dyslipidemia - report from WCCL 2025

07 Jul 2025

Contributed by Lukas

Professor Martin Clodi shares his insights what clinicians must know about diabetic dyslipidemia at the 4th World Congress of Lipidology in Vienna, Au...

How to implement LDL guidelines? - report from WCCL 2025

04 Jul 2025

Contributed by Lukas

Professor Gerald Watts shares his insights how to implement LDL guidelines at the 4th World Congress of Lipidology in Vienna, Austria.Video: https://m...

Newborn Screening for Atherosclerosis Risk? - report from WCCL 2025

04 Jul 2025

Contributed by Lukas

Professor Caroline Bachmeier shares her insights on the rationale of small children and newborn screening for atherosclerosis at the 4th World Congres...

What will change in the lipid lowering landscape in the next 5 years? - report from WCCL 2025

04 Jul 2025

Contributed by Lukas

Professor Maciej Banach shares his insights what will change in the lipid lowering landscape in the next 5 years at the 4th World Congress of Lipidolo...

Diabetic Dyslipidemia: Beyond LDL – Atherogenic Lipoproteins in Focus - report from WCCL 2025

03 Jul 2025

Contributed by Lukas

Professor Gersina Rega Kaun shares her insights on lipid lowering in diabetics at the 4th World Congress of Lipidology in Vienna, Austria.Video: https...

LDL lowering in 2025: Optimal approach - report from WCCL 2025

03 Jul 2025

Contributed by Lukas

Professor Dereck Connolly shares his insights on LDL lowering in 2025 at the 4th World Congress of Lipidology in Vienna, Austria.Video: https://medica...

POLARGO Trial Shows OS Benefit with Pola-R-GemOx in Transplant-Ineligible R/R DLBCL - report from EHA2025

27 Jun 2025

Contributed by Lukas

Professor Matthew Matasar explains the highly anticipated results of the Phase III POLARGO trial after the 2025 EHA Annual Meeting.Video: https://medi...

Asciminib in the treatment of CML - report from EHA2025

27 Jun 2025

Contributed by Lukas

Professor Dennis Kim shares his insights on the asciminib in the treatment of chronic myeloid leukemia after the 2025 EHA Annual Meeting.Video: https:...

AML Highlights from EHA 2025

27 Jun 2025

Contributed by Lukas

Professor Petya Apostolova shares her insights on the Acute Myeloid Leukemia highlights from the 2025 EHA Annual Meeting.Video: https://medicaldigest....

Advances in Post-Covalent Bruton`s Tyrosine Kinase Inhibitor Therapy for Relapsed/Refractory Chronic Lymphocytic Leukemia - report from EHA2025

27 Jun 2025

Contributed by Lukas

Professor Matthew Davids shares his insights on the advances in post-covalent Bruton`s tyrosine kinase inhibitor therapy for relapsed/refractory chron...

Frontline Therapy of B-cell Acute Lymphoblastic Leukemia: Harnessing Innovative Approaches to Improve Outcomes - report from EHA2025

27 Jun 2025

Contributed by Lukas

Professor Martin Schrappe shares his insights on the frontline therapy of B-cell acute lymphoblastic leukemia at the 2025 EHA Annual Meeting.Video: ht...

Diffuse large B cell lymphoma: Bispecifics in focus - report from EHA2025

26 Jun 2025

Contributed by Lukas

Professor Martin Hutchings shares his insights on the role of bispecifics int the treatment of diffuse large B cell lymphoma at the 2025 EHA Annual Me...

How to educate haematologists to better identify Gaucher disease? - report from EHA2025

26 Jun 2025

Contributed by Lukas

Professor Sam Salek discusses how to educate haematologists to better identify Gaucher disease at the 2025 EHA Annual Meeting.Video: https://medicaldi...

Management of Multiple Myeloma at EHA 2025

26 Jun 2025

Contributed by Lukas

Professor Evangelos Terpos shares his insights on the management of Multiple Myeloma at the 2025 EHA Annual Meeting.Video: https://medicaldigest.org/s...

Highlights of Diffuse Large B-Cell Lymphoma at EHA 2025

26 Jun 2025

Contributed by Lukas

Professor Thomas Oellerich shares his insights on the highlights of Diffuse Large B-Cell Lymphoma at the 2025 EHA Annual Meeting.Video: https://medica...

Emerging Insights in the Secondary Acute Myeloid Leukemia in 2025 - report from EHA2025

26 Jun 2025

Contributed by Lukas

Professor Agnieszka Wierzbowska shares her thoughts on emerging insights in the secondary acute myeloid leukemia at the 2025 EHA Annual Meeting.Video:...

Combination Therapy For The Treatment Of Hypertension - report from ESH2025

26 Jun 2025

Contributed by Lukas

Professor Paul K. Whelton shares his insights on combination therapy for the treatment of hypertension after the 34th European Meeting on Hypertension...

The Role of CAR T-cell Therapy in Multiple Myeloma - report from EHA2025

25 Jun 2025

Contributed by Lukas

Professor Doris Hansen shares her insights on the role of CAR T-cell therapy in Multiple Myeloma at the 2025 EHA Annual Meeting.Video: https://medical...

Multiple Myeloma update at EHA 2025

25 Jun 2025

Contributed by Lukas

Professor Andrzej Jakubowiak shares his insights on multiple myeloma updates at the 2025 EHA Annual Meeting.Video: https://medicaldigest.org/scientifi...

Shaping the Treatment Landscape in Myelodysplastic Syndromes and Acute Myeloid Leukemia - report from EHA2025

25 Jun 2025

Contributed by Lukas

Professor Gail Roboz shares her insights on the treatment landscape in myelodysplastic syndromes and acute myeloid leukemia at the 2025 EHA Annual Mee...

New therapeutic options and translational insights in ALL - report from EHA2025

25 Jun 2025

Contributed by Lukas

Professor Cristina Papayannidis shares her insights on the new therapeutic options in acute lymphocytic leukemia at the 2025 EHA Annual Meeting.Video:...

Exploring the Landscape for FLT3-mutated Relapsed/Refractory Acute Myeloid Leukaemia - report from EHA2025

25 Jun 2025

Contributed by Lukas

Professor Adolfo de la Fuente Burguera shares his insights on the landscape for FLT3-mutated relapsed/refractory acute myeloid leukaemia at the 2025 E...

How to Improve the Awareness in Gaucher Disease? - report from EHA2025

25 Jun 2025

Contributed by Lukas

Professor Pilar Giraldo shares her insights on how to improve the awareness in Gaucher disease at the 2025 EHA Annual Meeting.Video: https://medicaldi...

Mapping the Evolving Chronic Lymphocytic Leukemia Treatment Landscape for the Optimal Patient Journey and Experience - report from EHA2025

25 Jun 2025

Contributed by Lukas

Professor Dima El-Sharkawi shares her insights on the evolving chronic lymphocytic leukemia treatment landscape for the optimal patient journey and ex...

Optimising the Management of FLT3mut+ R/R AML - report from EHA2025

25 Jun 2025

Contributed by Lukas

Professor Mark Levis shares his insights on optimising the management of FLT3mut+ R/R AML at the 2025 EHA Annual Meeting.Video: https://medicaldigest....

ALL Highlights from EHA 2025

23 Jun 2025

Contributed by Lukas

Professor Sebastian Giebel shares his insights on the Acute Lymphoblastic Leukemia highlights from the 2025 EHA Annual Meeting.Video: https://medicald...

First-Steps With Time-Limited BTKi-B–cell lymphoma 2 Inhibitor Options in Treatment Naïve CLL - report from EHA2025

23 Jun 2025

Contributed by Lukas

Professor Lydia Scarfò shares her insights on BTKi-B–cell lymphoma 2 inhibitor options in treatment naïve CLL at the 2025 EHA Annual Meeting.Video...

Improving Patient Outcome in Secondary Acute Myeloid Leukemia in 2025 - report from EHA2025

23 Jun 2025

Contributed by Lukas

Professor Livio Pagano discusses improving patient outcome in secondary acute myeloid leukemia at the 2025 EHA Annual Meeting.Video: https://medicaldi...

The Second Coming of Finite Therapy in Chronic Lymphocytic Leukemia - report from EHA2025

23 Jun 2025

Contributed by Lukas

Professor Nicole Lamanna shares her insights on second-generation BTKi combinations at the 2025 EHA Annual Meeting.Video: https://medicaldigest.org/sc...

The Unprecedented Progress on the Treatment of Relapsed and Refractory Multiple Myeloma in 2025 - report from EHA2025

23 Jun 2025

Contributed by Lukas

Professor Enrique M. Ocio discusses progress on the treatment of relapsed and refractory multiple myeloma at the 2025 EHA Annual Meeting.Video: https:...

Honorary President's take on the highlights of ESH 2025 meeting - report from ESH2025

17 Jun 2025

Contributed by Lukas

Professor Giuseppe Mancia shares his insights on the most inportant highlights of ESH 2025 meeting. Video: https://medicaldigest.org/scientific-conten...

Build a strong therapeutic alliance with your patient: with a little help from your friends - report from ESH2025

17 Jun 2025

Contributed by Lukas

Professor Michel Burnier participated in a session of the 34th European Meeting on Hypertension and Cardiovascular protection in Milan, Italy which ad...

Let’s target success for every patient: Achieving blood pressure control in high-risk patients - report from ESH2025

17 Jun 2025

Contributed by Lukas

Professor George S. Stergiou co-chaired a session at the 34th European Meeting on Hypertension and Cardiovascular protection in Milan, Italy focused o...

Patients and doctors’ partnership: Should we change the paradigm to improve blood pressure control? - report from ESH2025

17 Jun 2025

Contributed by Lukas

Professor Rosa de Pinho co-chaired a session at the 34th European Meeting on Hypertension and Cardiovascular protection in Milan, Italy focused on fac...

Cracking the code of resistant hypertension: From challenges to solutions - report from ESH2025

17 Jun 2025

Contributed by Lukas

Professor Stefano Taddei shares his insights on resistant hypertension, that has been thoroughly discussed at many sessions of the 34th European Meeti...

Combining vaccines is the future of vaccination - report from WVCDC 2025

07 May 2025

Contributed by Lukas

Mark Jit shares his insights on the combination vaccines on the future of vaccination at the World Vaccine Congress Washington 2025.Video: https://med...

Addressing the burden of long Covid: reaching a global consensus - report from WVCDC 2025

07 May 2025

Contributed by Lukas

Miranda Baxa shares her insights on the burden of long Covid at the World Vaccine Congress Washington 2025.Important documents:The future of covid Add...

Benefits and challenges of combining vaccines - report from WVCDC 2025

07 May 2025

Contributed by Lukas

Bill Hausdorff shares his insights on the benefits and challenges of combining vaccines at the World Vaccine Congress Washington 2025.Video: https://m...

Which vaccination programs with pandemic potential have worked and what else can be done to repurpose COVID facilities and incorporate novel platforms? - report from WVCDC 2025

07 May 2025

Contributed by Lukas

Rajinder Suri shares his insights on which vaccination programs with pandemic potential have worked and what else can be done to repurpose COVID facil...